Glucose + Nacl Viaflo Baxter (Sodium Chloride, Glucose)

Glucose + NaCl Viaflo Baxter is used in clinical settings where rapid restoration of intravascular volume, electrolytes, and caloric support is required.

• Rehydration of patients with fluid loss due to surgery, trauma, or severe dehydration.
• Replacement of sodium and chloride deficits in patients receiving diuretics or gastrointestinal losses.
• Provision of an immediate source of glucose for patients unable to tolerate oral intake.
• Support of peri‑operative fluid management in anesthesia and intensive care units.
• Adjunct therapy during parenteral nutrition when additional electrolytes are needed.

Intravenous administration of Glucose + NaCl Viaflo Baxter may be associated with a range of observed effects, most of which are related to the solution’s composition and infusion characteristics.

Common

• Mild hyperglycemia, especially in patients with impaired glucose tolerance.
• Transient increase in serum sodium or chloride levels.
• Local irritation or pain at the infusion site.
• Fluid overload signs such as peripheral edema in susceptible individuals.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Electrolyte imbalance causing cardiac arrhythmias.
• Anaphylactic or severe hypersensitivity reactions to the formulation.

Clinicians should consider several precautions before prescribing Glucose + NaCl Viaflo Baxter to ensure patient safety and optimal therapeutic outcomes.

• Assess baseline blood glucose and electrolyte levels prior to infusion.
• Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload.
• Use caution in individuals with known hypersensitivity to any component of the solution.
• Monitor serum sodium, chloride, and glucose regularly during and after administration.
• Avoid rapid bolus administration; prefer controlled infusion to reduce risk of circulatory stress.
• Consider alternative carbohydrate sources for patients with severe hyperglycemia.

Glucose + NaCl Viaflo Baxter can interact with other medications or clinical conditions, influencing its safety profile.

Avoid

• Concurrent high‑dose insulin therapy without glucose monitoring, which may precipitate hypoglycemia.
• Co‑administration with other hypertonic saline solutions, risking excessive sodium load.

Use with caution

• Diuretics that alter electrolyte balance, requiring close monitoring of sodium and chloride.
• Cardiac glycosides in patients with fluid overload, as increased volume may affect drug efficacy.
• Parenteral nutrition regimens containing additional glucose, to prevent hyperglycemia.
• Medications that affect renal function, such as aminoglycosides, which may modify electrolyte handling.